迈克生物(300463.SZ)：公司目前暂无已获证的尼帕病毒检测产品

Core Viewpoint - The company has stated that it currently does not have any certified Nipah virus testing products in response to recent developments regarding the Nipah virus in India [1] Group 1: Company Response - The company will evaluate its product strategy based on multiple dimensions, including the urgency of clinical needs, feasibility of technical implementation, and compliance with registration procedures [1] - The company emphasizes the importance of making prudent decisions and adhering to information disclosure obligations [1] Group 2: Investor Guidance - Investors are advised to pay attention to official information disclosure channels and to exercise caution in their investment decisions [1]